Restriction Spectrum MRI Technique Improves Diagnosis of Prostate Cancer
By MedImaging International staff writers Posted on 21 Jan 2015 |
New magnetic resonance imaging (MRI) technology could soon translate into more effective diagnoses and less invasive interventions for prostate cancer.
Investigators have recently reported on the innovative imaging technique, which measurably improves upon current prostate imaging, and may have significant implications for how patients with prostate cancer are ultimately treated.
Prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men in 2014. The group of scientists and physicians, from the University of California (UC), San Diego School of Medicine (USA), with colleagues at University of California, Los Angeles (UCLA; USA), published their findings in the January 6, 2015, issue of the journal Prostate Cancer and Prostatic Disease. “This new approach is a more reliable imaging technique for localizing tumors. It provides a better target for biopsies, especially for smaller tumors,” said Rebecca Rakow-Penner, MD, PhD, a research resident in the department of radiology and the study’s first author.
The technique is also beneficial in surgical planning and image staging, according to David S. Karow, MD, PhD, assistant professor of radiology at UC San Diego, and the study’s corresponding author. “Doctors at UC San Diego and UCLA now have a noninvasive imaging method to more accurately assess the local extent of the tumor and possibly predict the grade of the tumor, which can help them more precisely and effectively determine appropriate treatment.”
The current standard of care for detecting and diagnosing prostate cancer is contrast-enhanced magnetic resonance imaging (MRI), which involves intravenously injecting patients with a contrast agent to highlight blood flow. Greater blood flow is often a requirement of growing cancer cells. When compared to surrounding healthy tissues, it is hoped that contrast-enhanced MRI scans will reveal the shape and composition of any tumors present.
But many tumors do not significantly differ from surrounding healthy tissues with contrast enhanced MRI and so evade easy detection. An imaging technique called diffusion MRI measures the diffusion of water and has been a standard imaging technique in the brain and an emerging technique in the prostate. Cancer tissues are denser than healthy tissues and typically limit the amount and mobility of water within them. However, diffusion MRI suffers from magnetic field artifacts that can distort the actual location of tumors by as much as 1.2 cm—a substantial distance when surgeons are trying, for instance, to evaluate whether a tumor extends beyond the prostate and into adjacent nerve bundles.
The new imaging strategy in the study is called restriction spectrum imaging-MRI (RSI-MRI). It corrects for magnetic field distortions and focuses upon water diffusion within tumor cells. By doing both, the ability of imaging to accurately plot a tumor’s location is increased and there is a more refined sense of the tumor’s extent, according to Nathan White, PhD, assistant project scientist at UC San Diego, study coauthor, and co-inventor of the RSI-MRI technique.
In a related study to be published in the journal Frontiers in Oncology, the same researchers reported that RSI-MRI appears to predict tumor grade. Higher grade tumors correlate with higher restricted water volume in the cancer cells’ large nuclei. “Prostate cancer can often be an indolent disease, where a patient may only require surveillance rather than aggressive surgery,” noted coauthor Christopher J. Kane, MD, professor of urology at UC San Diego.
“If by imaging we could predict the tumor grade,” added Robert Reiter, MD, professor of urology at UCLA, “we may be able to spare some patients from prostate resection and monitor their cancer with imaging.”
Related Links:
University of California, San Diego
University of California, Los Angeles
Investigators have recently reported on the innovative imaging technique, which measurably improves upon current prostate imaging, and may have significant implications for how patients with prostate cancer are ultimately treated.
Prostate cancer was the leading cause of newly diagnosed cancers in men and the second leading cause of cancer death in men in 2014. The group of scientists and physicians, from the University of California (UC), San Diego School of Medicine (USA), with colleagues at University of California, Los Angeles (UCLA; USA), published their findings in the January 6, 2015, issue of the journal Prostate Cancer and Prostatic Disease. “This new approach is a more reliable imaging technique for localizing tumors. It provides a better target for biopsies, especially for smaller tumors,” said Rebecca Rakow-Penner, MD, PhD, a research resident in the department of radiology and the study’s first author.
The technique is also beneficial in surgical planning and image staging, according to David S. Karow, MD, PhD, assistant professor of radiology at UC San Diego, and the study’s corresponding author. “Doctors at UC San Diego and UCLA now have a noninvasive imaging method to more accurately assess the local extent of the tumor and possibly predict the grade of the tumor, which can help them more precisely and effectively determine appropriate treatment.”
The current standard of care for detecting and diagnosing prostate cancer is contrast-enhanced magnetic resonance imaging (MRI), which involves intravenously injecting patients with a contrast agent to highlight blood flow. Greater blood flow is often a requirement of growing cancer cells. When compared to surrounding healthy tissues, it is hoped that contrast-enhanced MRI scans will reveal the shape and composition of any tumors present.
But many tumors do not significantly differ from surrounding healthy tissues with contrast enhanced MRI and so evade easy detection. An imaging technique called diffusion MRI measures the diffusion of water and has been a standard imaging technique in the brain and an emerging technique in the prostate. Cancer tissues are denser than healthy tissues and typically limit the amount and mobility of water within them. However, diffusion MRI suffers from magnetic field artifacts that can distort the actual location of tumors by as much as 1.2 cm—a substantial distance when surgeons are trying, for instance, to evaluate whether a tumor extends beyond the prostate and into adjacent nerve bundles.
The new imaging strategy in the study is called restriction spectrum imaging-MRI (RSI-MRI). It corrects for magnetic field distortions and focuses upon water diffusion within tumor cells. By doing both, the ability of imaging to accurately plot a tumor’s location is increased and there is a more refined sense of the tumor’s extent, according to Nathan White, PhD, assistant project scientist at UC San Diego, study coauthor, and co-inventor of the RSI-MRI technique.
In a related study to be published in the journal Frontiers in Oncology, the same researchers reported that RSI-MRI appears to predict tumor grade. Higher grade tumors correlate with higher restricted water volume in the cancer cells’ large nuclei. “Prostate cancer can often be an indolent disease, where a patient may only require surveillance rather than aggressive surgery,” noted coauthor Christopher J. Kane, MD, professor of urology at UC San Diego.
“If by imaging we could predict the tumor grade,” added Robert Reiter, MD, professor of urology at UCLA, “we may be able to spare some patients from prostate resection and monitor their cancer with imaging.”
Related Links:
University of California, San Diego
University of California, Los Angeles
Latest MRI News
- Ultra-Powerful MRI Scans Enable Life-Changing Surgery in Treatment-Resistant Epileptic Patients
- AI-Powered MRI Technology Improves Parkinson’s Diagnoses
- Biparametric MRI Combined with AI Enhances Detection of Clinically Significant Prostate Cancer
- First-Of-Its-Kind AI-Driven Brain Imaging Platform to Better Guide Stroke Treatment Options
- New Model Improves Comparison of MRIs Taken at Different Institutions
- Groundbreaking New Scanner Sees 'Previously Undetectable' Cancer Spread
- First-Of-Its-Kind Tool Analyzes MRI Scans to Measure Brain Aging
- AI-Enhanced MRI Images Make Cancerous Breast Tissue Glow
- AI Model Automatically Segments MRI Images
- New Research Supports Routine Brain MRI Screening in Asymptomatic Late-Stage Breast Cancer Patients
- Revolutionary Portable Device Performs Rapid MRI-Based Stroke Imaging at Patient's Bedside
- AI Predicts After-Effects of Brain Tumor Surgery from MRI Scans
- MRI-First Strategy for Prostate Cancer Detection Proven Safe
- First-Of-Its-Kind 10' x 48' Mobile MRI Scanner Transforms User and Patient Experience
- New Model Makes MRI More Accurate and Reliable
- New Scan Method Shows Effects of Treatment on Lung Function in Real Time
Channels
Radiography
view channel
AI-Powered Imaging Technique Shows Promise in Evaluating Patients for PCI
Percutaneous coronary intervention (PCI), also known as coronary angioplasty, is a minimally invasive procedure where small metal tubes called stents are inserted into partially blocked coronary arteries... Read more
Higher Chest X-Ray Usage Catches Lung Cancer Earlier and Improves Survival
Lung cancer continues to be the leading cause of cancer-related deaths worldwide. While advanced technologies like CT scanners play a crucial role in detecting lung cancer, more accessible and affordable... Read moreUltrasound
view channel
Tiny Magnetic Robot Takes 3D Scans from Deep Within Body
Colorectal cancer ranks as one of the leading causes of cancer-related mortality worldwide. However, when detected early, it is highly treatable. Now, a new minimally invasive technique could significantly... Read more
High Resolution Ultrasound Speeds Up Prostate Cancer Diagnosis
Each year, approximately one million prostate cancer biopsies are conducted across Europe, with similar numbers in the USA and around 100,000 in Canada. Most of these biopsies are performed using MRI images... Read more
World's First Wireless, Handheld, Whole-Body Ultrasound with Single PZT Transducer Makes Imaging More Accessible
Ultrasound devices play a vital role in the medical field, routinely used to examine the body's internal tissues and structures. While advancements have steadily improved ultrasound image quality and processing... Read moreNuclear Medicine
view channel
Novel PET Imaging Approach Offers Never-Before-Seen View of Neuroinflammation
COX-2, an enzyme that plays a key role in brain inflammation, can be significantly upregulated by inflammatory stimuli and neuroexcitation. Researchers suggest that COX-2 density in the brain could serve... Read more
Novel Radiotracer Identifies Biomarker for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC), which represents 15-20% of all breast cancer cases, is one of the most aggressive subtypes, with a five-year survival rate of about 40%. Due to its significant heterogeneity... Read moreGeneral/Advanced Imaging
view channel
AI-Powered Imaging System Improves Lung Cancer Diagnosis
Given the need to detect lung cancer at earlier stages, there is an increasing need for a definitive diagnostic pathway for patients with suspicious pulmonary nodules. However, obtaining tissue samples... Read more
AI Model Significantly Enhances Low-Dose CT Capabilities
Lung cancer remains one of the most challenging diseases, making early diagnosis vital for effective treatment. Fortunately, advancements in artificial intelligence (AI) are revolutionizing lung cancer... Read moreImaging IT
view channel
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
GE HealthCare and NVIDIA Collaboration to Reimagine Diagnostic Imaging
GE HealthCare (Chicago, IL, USA) has entered into a collaboration with NVIDIA (Santa Clara, CA, USA), expanding the existing relationship between the two companies to focus on pioneering innovation in... Read more
Patient-Specific 3D-Printed Phantoms Transform CT Imaging
New research has highlighted how anatomically precise, patient-specific 3D-printed phantoms are proving to be scalable, cost-effective, and efficient tools in the development of new CT scan algorithms... Read more
Siemens and Sectra Collaborate on Enhancing Radiology Workflows
Siemens Healthineers (Forchheim, Germany) and Sectra (Linköping, Sweden) have entered into a collaboration aimed at enhancing radiologists' diagnostic capabilities and, in turn, improving patient care... Read more